Skip to main content
Premium Trial:

Request an Annual Quote

10X Genomics' GemCode

10X Genomics this week launched the GemCode sequencing platform at the Advances in Genome Biology and Technology in Marco Island, Fla. GemCode is a molecular barcoding and analysis platform that consists of instrumentation, reagents, and software, and delivers long-range information including haplotype phasing, structural variation, and de novo assembly. The platform partitions arbitrarily long DNA molecules, including those greater than 100 kb, and prepares sequencing libraries in parallel so that all fragments produced within a partition share a common barcode. A simple workflow combines large partition numbers with a massively diverse barcode library to generate more than 100,000 barcode-containing partitions, while only requiring about 1ng of DNA input, the company said.

10X Genomics is accepting purchase orders for the GemCode instrument at $75,000 and will begin shipping in the second quarter of 2015.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.